On Thursday, December 17, at 3:00 p.m. Eastern, the American Society of Clinical Oncology (ASCO) and the Infectious Diseases Society of America (IDSA) will host a panel discussion on the use of the COVID-19 vaccines for cancer patients.
The panel will include experts in infectious diseases and oncology and will discuss available data on vaccine safety and efficacy, use of vaccines in immunocompromised patients, and management of adverse reactions. Don't miss this free webinar. Pre-register today.
I wanted to let you know that the recording of this webinar is now available and can be found on:ASCO's website https://www.asco.org/asco-coronavirus-information/provider-practice-preparedness-covid-19IDSA's website at https://www.idsociety.org/multimedia/clinician-calls/ASCO-IDSA-webinar-the-covid-19-vaccine-and-patients-with-cancer/Below is a list of additional COVID-19 resources available from ASCO and IDSA related to COVID-19:ASCO's COVID-19 Provider 7 Practice Information website: https://www.asco.org/asco-coronavirus-informationIDSA's COVID-19 Real-Time Learning Network: https://www.idsociety.org/covid-19-real-time-learning-network/**Note IDSA and the CDC hold a standing call each Saturday for clinicians of all specialties to learn from experts about timely COVID-19 issues. Learn more here: https://www.idsociety.org/multimedia/clinician-call/
The following are links to resources mentioned during the webinar:The Pfizer-BioNTech vaccine components: https://www.cvdvaccine-us.com/images/pdf/fact-sheet-for-hcp-administering-vaccine-vaccination-providers-full-eua-prescribing-information.pdf#page=11
CDC Pfizer Clinical Considerations: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/clinical-considerations.html
Please submit your questions or comments to: firstname.lastname@example.org.